Ola Blixt - Nanotechnology

Author Information

Ola Blixt is affiliated with the Chemical Glyco-Biology section, Department of Chemistry, University of Copenhagen, located in Copenhagen, Denmark. His research primarily focuses on glyco-biology and its applications in understanding disease mechanisms and potential biomarkers, which is evident from his extensive body of work.

Research Contributions

Ola Blixt has made significant contributions to the field of glyco-biology and nanotechnology. His research spans various topics, including the detection of anti-glycan antibodies as potential cancer biomarkers, engineering ligand specificity in human galectin, and studying the host range of influenza A viruses. His work has implications for cancer diagnostics, antiviral studies, and the understanding of immune response mechanisms. Notable contributions include the development of novel antibodies and the evaluation of specific biomarkers for diseases such as epithelial ovarian tumors.

Aliases

Ola Blixt is also known by the names O Blixt and O. Blixt.

Publication and Citation Metrics

Metrics	Values
Citation Count	10117
H-index	49
Paper Count	139

Publications:

Amplified suspension magnetic bead-based assay for sensitive detection of anti-glycan antibodies as potential cancer biomarkers.

DOI: 10.1016/j.aca.2022.339444

Year: 2022

Engineering the Ligand Specificity of the Human Galectin‐1 by Incorporation of Tryptophan Analogues

DOI: 10.1002/cbic.202100593

Year: 2022

Reversible derivatization of sugars with carbobenzyloxy groups and use of the derivatives in solution-phase enzymatic oligosaccharide synthesis.

DOI: 10.1016/j.carres.2021.108272

Year: 2021

Evaluation of Sialyl-Lactotetra as a Marker for Epithelial Ovarian Tumors

DOI: 10.3389/fonc.2020.561888

Year: 2020

PODO447: a novel antibody to a tumor-restricted epitope on the cancer antigen podocalyxin

DOI: 10.1136/jitc-2020-001128

Year: 2020

Host Range of Influenza A Virus H1 to H16 in Eurasian Ducks Based on Tissue and Receptor Binding Studies

DOI: 10.1128/JVI.01873-20

Year: 2020

Structural characterization of an unprecedented lectin-like antitumoral anti-MUC1 antibody.

DOI: 10.1039/d0cc06349e

Year: 2020

Specificity of human natural antibodies referred to as anti-Tn.

DOI: 10.1016/j.molimm.2020.02.005

Year: 2020

The Repertoire of Human Antiglycan Antibodies and Its Dynamics in the First Year of Life

DOI: 10.1134/S0006297919060038

Year: 2019

Assessing the interspecies transmission mechanisms of influenza A viruses

DOI:

Year: 2019

What are the Applications of Scooping?

How is YSZ Synthesized at the Nanoscale?

What are the Challenges in Assessing Environmental Risks?

What are the Future Trends in Nanotechnology Imaging?

What are the Key Challenges in Accelerated Aging Tests for Nanotechnology?

What are Some Common Metallic Nanoparticles?

What is the Future of Nanocrystals?

What Agencies are Involved in Nanotechnology Registration?

What are the Applications of Acoustic Waves in Nanotechnology?

How is Single Photon Counting Relevant to Nanotechnology?

Partnered Content Networks

Relevant Topics